DrugPatentWatch Database Preview

Methylprednisolone - Generic Drug Details

« Back to Dashboard

What are the generic sources for methylprednisolone and what is the scope of freedom to operate?

Methylprednisolone is the generic ingredient in eleven branded drugs marketed by Pfizer, Duramed Pharms Barr, Heather, Invatech, Jubilant Cadista, Lupin Ltd, Novast Labs, Par Pharm, Praxgen, Sandoz, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms, Pharmacia And Upjohn, Bel Mar, Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Teva Parenteral, and Tianjin Kingyork, and is included in eighty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone. Thirty suppliers are listed for this compound.

Summary for methylprednisolone

US Patents:	0
Tradenames:	11
Applicants:	34
NDAs:	86
Drug Master File Entries:	40
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	83
Clinical Trials:	639
Patent Applications:	7,268
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for methylprednisolone
Drug Sales Revenues:	Drug sales revenues for methylprednisolone
What excipients (inactive ingredients) are in methylprednisolone?	methylprednisolone excipients list
DailyMed Link:	methylprednisolone at DailyMed

See drug prices for methylprednisolone

See drug sales revenues for methylprednisolone

Recent Clinical Trials for methylprednisolone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Haukeland University Hospital	Phase 2
Università degli Studi dell'Insubria	Phase 3
University of Catania	Phase 3

See all methylprednisolone clinical trials

Pharmacology for methylprednisolone

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for methylprednisolone

Anti-Inflammatory Agents

Antiemetics

Glucocorticoids

Neuroprotective Agents

US Patents and Regulatory Information for methylprednisolone

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	207667-001	Dec 15, 2015	AP	RX	No	No
Watson Labs	METHYLPREDNISOLONE ACETATE	methylprednisolone acetate	INJECTABLE;INJECTION	085595-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva Pharms Usa	METHYLPREDNISOLONE ACETATE	methylprednisolone acetate	INJECTABLE;INJECTION	040620-002	Oct 27, 2006	AB	RX	No	No
Bedford Labs	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	040662-001	Feb 21, 2007		DISCN	No	No
Abraxis Pharm	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	088676-001	Jun 8, 1984		DISCN	No	No
Heather	METHYLPREDNISOLONE	methylprednisolone	TABLET;ORAL	085650-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Abraxis Pharm	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	088677-001	Jun 8, 1984		DISCN	No	No